Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Reports First Quarter 2023 Financial Results and Business Highlights
Freeline Reports Full Year 2020 Financial Results and Business Highlights
Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease
Freeline Reports January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate for Gaucher Disease, in Late-Breaking Oral Presentation at ASGCT 27th Annual Meeting
Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels